Launching a new medication in a complex disease state is often fraught with complications that can impact medication adherence. While new medications can improve a patient’s quality of life, unexpected or misunderstood side effects can trigger fears that the medication is having an adverse effect or worsening their condition, resulting in patients abandoning treatment.
This case study presents the ways in which three organizations collaborated to design a patient support program to help women diagnosed with an aggressive form of breast cancer stay adherent to life-extending therapy.
You’ll learn how their holistic approach led to:
OptimizeRx Corporation (NASDAQ: OPRX) is a pioneering digital health company that provides healthcare communications solutions for life sciences to engage in streamlined, outcomes-focused dialogue with healthcare providers and patients. Connecting more than half of healthcare providers in the US through a proprietary electronic health network, the OptimizeRx digital health and communications platform is a SaaS solution supporting treatment access and adherence by advancing affordability and transparency. The platform unlocks novel patient and provider touchpoints for life sciences along the complete longitudinal patient journey, from both ambulatory and hospital point-of-care, to retail pharmacy, through patient engagement outside the care setting.
OptimizeRx Corporation
+1 (248) 651-6568